<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="utf-8">
<meta name="viewport" content="width=device-width,initial-scale=1">
<title>High-throughput REIMS distinguishes Candida species — pCite</title>
<link rel="stylesheet" href="../css/style.css">
</head>
<body>
<header>
  <h1><a href="../index.html">pCite</a></h1>
  <nav><a href="../index.html">Search</a><a href="../corpus.html">Corpus</a></nav>
</header>

<p class="section-label">CLAIM</p>
<hr class="section-rule">
<div class="triple">
  <strong>High-throughput REIMS</strong>
  <span class="pred">&mdash;distinguishes&rarr;</span>
  <strong>Candida species</strong>
</div>
<div class="entity-id">UNKNOWN:high-throughput reims &nbsp;&middot;&nbsp; MESH:D002178</div>

<p class="section-label">VALIDATION</p>
<hr class="section-rule">
<div class="val-bar" style="--pct:100%;--color:#2ca02c"></div>
<div class="stat-row">
  <span>Class: Physical (10.0)</span>
  <span>Replicated: 1 paper</span>
  <span>Score: 122.90<span class="score-tip"><span class="tip-icon">&nbsp;&#9432;</span><span class="tip-text">Score = &Sigma; incoming citation weights. Each citation is weighted by the validation class of the source claim (Physical 10.0 &middot; Curated 0.5 &middot; AI 0.01) multiplied by the citation type (Replicates 1.5 &middot; Supports 1.0 &middot; Contradicts 0.8). A score of 364 means this claim received strong physical-tier citation support.</span></span></span>
</div>

<p class="section-label">SCORE BREAKDOWN</p>
<hr class="section-rule">
<div class="score-breakdown">Base weight: 10.00 (Physical, 1 paper)<br>Score from 21 citations: <strong>122.90</strong><br><span style="color:#888">6&times; extends (+60.60) &middot; 13&times; supports (+54.00) &middot; 1&times; contradicts (+8.00) &middot; 1&times; applies (+0.30)</span></div>


<p class="section-label">EVIDENCE CHAIN &middot; 1 source</p>
<hr class="section-rule">
<div class="evidence-row"><span class="evidence-dot" style="background:#2ca02c" title="Physical"></span><span>Physical</span><a href="https://doi.org/10.1038/srep36788">10.1038/srep36788</a> <a href="https://www.ebi.ac.uk/metabolights/MTBLS383">MTBLS383</a></div>


<p class="section-label">CITATIONS RECEIVED &middot; 21 total</p>
<hr class="section-rule">
<div class="cite-bar"><span style="width:70px;text-align:right">Replicates</span><span class="cite-bar-fill" style="width:0px"></span><span>0</span></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Supports</span><span class="cite-bar-fill" style="width:100px"></span><span>13</span><span class="cite-subtotal">&middot; +54.00</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">sphingomyelins — is_biomarker_for → cervical intraepithelial neoplasia</span><span class="cite-claim-weight">+10.00</span><a href="../claim/be164edf9a91ec34.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">glycerophospholipids — is_biomarker_for → cervical intraepithelial neoplasia</span><span class="cite-claim-weight">+10.00</span><a href="../claim/331ac46780c8961d.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">phosphatidylcholine (PC 16:0/18:1) — decreases → cervical intraepithelial neoplasia grade 2+</span><span class="cite-claim-weight">+10.00</span><a href="../claim/04f713c01be9337e.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">sphingomyelin (SM 34:1) — decreases → cervical intraepithelial neoplasia grade 2+</span><span class="cite-claim-weight">+10.00</span><a href="../claim/2917d6e529a0e591.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">lipid metabolomics profile — correlates_with → HPV infection</span><span class="cite-claim-weight">+10.00</span><a href="../claim/21671d2ed570ca4b.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">APC loss — increases → adenosylhomocysteinase (AHCY)</span><span class="cite-claim-weight">+0.50</span><a href="../claim/0e679032f929d07f.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">APC loss — causes → methionine cycle dysregulation</span><span class="cite-claim-weight">+0.50</span><a href="../claim/9ed8b178e78cd001.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">AHCY — is_biomarker_for → colorectal cancer</span><span class="cite-claim-weight">+0.50</span><a href="../claim/90eb8cbd0642a10b.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">AHCY inhibition — decreases → APC-deficient organoid growth</span><span class="cite-claim-weight">+0.50</span><a href="../claim/30b0b6b77279c8c2.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">AHCY inhibition — decreases → hyperproliferative/crypt progenitor phenotype</span><span class="cite-claim-weight">+0.50</span><a href="../claim/c7daaab1f4ca7622.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">AHCY inhibition — treats → intestinal tumour burden in ApcMin/+ mice</span><span class="cite-claim-weight">+0.50</span><a href="../claim/99cf0afae100c9e0.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">adenosylhomocysteine — is_metabolite_of → methionine cycle</span><span class="cite-claim-weight">+0.50</span><a href="../claim/8e400ab376a59234.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">methionine cycle dysregulation — is_biomarker_for → APC-deficient colorectal cancer</span><span class="cite-claim-weight">+0.50</span><a href="../claim/ce956ec97efef970.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Contradicts</span><span class="cite-bar-fill" style="width:8px"></span><span>1</span><span class="cite-subtotal">&middot; +8.00</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">phosphatidylcholines — is_biomarker_for → cervical intraepithelial neoplasia</span><span class="cite-claim-weight">+8.00</span><a href="../claim/cd79a62bec79959c.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Extends</span><span class="cite-bar-fill" style="width:46px"></span><span>6</span><span class="cite-subtotal">&middot; +60.60</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">LA-REIMS metabolomics profile — distinguishes → cervical intraepithelial neoplasia grade 2+</span><span class="cite-claim-weight">+12.00</span><a href="../claim/8210ebce2e2e9b3d.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">LA-REIMS metabolomics profile — distinguishes → cervical cancer</span><span class="cite-claim-weight">+12.00</span><a href="../claim/c3584fa9aa32ef6c.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">LA-REIMS metabolomics profile — distinguishes → HPV-positive vs HPV-negative cervical samples</span><span class="cite-claim-weight">+12.00</span><a href="../claim/5dabb921175a33fa.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">cervical metabolomics profile (LA-REIMS) — predicts → cervical intraepithelial neoplasia grade 2+</span><span class="cite-claim-weight">+12.00</span><a href="../claim/abd4a04337420de5.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">LA-REIMS cervical metabolomics — distinguishes → high-grade squamous intraepithelial lesion vs normal cervix</span><span class="cite-claim-weight">+12.00</span><a href="../claim/e756bf22c5963fa7.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">untargeted metabolic profiling — distinguishes → colorectal cancer genetic subtypes</span><span class="cite-claim-weight">+0.60</span><a href="../claim/5b18c2366e403513.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Applies</span><span class="cite-bar-fill" style="width:8px"></span><span>1</span><span class="cite-subtotal">&middot; +0.30</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">mass spectrometry imaging — distinguishes → tumour, stromal and normal adjacent intestinal tissues</span><span class="cite-claim-weight">+0.30</span><a href="../claim/0ec085732cfae5c8.html">view &rarr;</a></div>


<p class="section-label">IDENTIFIERS</p>
<hr class="section-rule">
<table class="id-table">
<tr><td>Claim ID</td><td><code>cbe0c7a31fb98572</code></td></tr>
<tr><td>Subject URI</td><td><a href="https://identifiers.org/UNKNOWN:high-throughput reims">UNKNOWN:high-throughput reims</a></td></tr>
<tr><td>Object URI</td><td><a href="https://identifiers.org/MESH:D002178">MESH:D002178</a></td></tr>
</table>
<footer>pCite — validation-weighted scientific claims</footer>
</body>
</html>
